UBS Group AG and UBS AG, through its Stamford branch, have announced corrected pricing terms for their previously disclosed cash tender offers involving seven separate series of outstanding notes. The updated information follows the expiration of the offers at 5:00 p.m. Eastern time on November 5, 2025.
According to UBS, a total combined principal amount of $7,668,817,115 in notes has been accepted for purchase, not including those delivered under guaranteed delivery procedures. The company stated that "the Maximum Purchase Condition (after giving effect to the increase announced on November 6, 2025) has been satisfied with respect to the Offers in respect of the series of Notes with Acceptance Priority Levels of 1 - 6." All validly tendered notes from these series that were not withdrawn by the deadline have been accepted for purchase.
However, UBS did not accept any notes classified as Acceptance Priority Level 7 and will return all validly tendered notes from this category to their holders.
Holders whose notes are accepted will receive a cash payment covering accrued and unpaid interest up to but excluding the initial settlement date of November 7, 2025. Interest will cease accruing on this date for all purchased notes. Those who submitted under guaranteed delivery procedures and whose notes are accepted will not receive interest payments for periods after the initial settlement date.
UBS emphasized that "this press release is neither an offer to purchase nor a solicitation of an offer to sell the Notes or any other securities." The company clarified that participation in these offers was only available under terms specified in official documents and subject to applicable laws. No recommendations regarding participation were made by UBS or associated parties.
Investors seeking more information can contact UBS representatives in Switzerland at +41-44-234 41 00 or in the Americas at +1 212 882 57 34.